Cadence Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-112,670
Closed -$4.65M 640
2015
Q2
$4.65M Buy
+112,670
New +$4.13M 0.26% 102
2014
Q4
Sell
-128,801
Closed -$2.56M 645
2014
Q3
$2.56M Sell
128,801
-102,250
-44% -$2.15M 0.14% 197
2014
Q2
$5.27M Sell
231,051
-200,117
-46% -$3.56M 0.25% 123
2014
Q1
$5.54M Buy
431,168
+51,908
+14% +$744K 0.23% 174
2013
Q4
$5.17M Buy
379,260
+258,490
+214% +$3.09M 0.2% 214
2013
Q3
$1.34M Sell
120,770
-24,920
-17% -$248K 0.05% 360
2013
Q2
$1.2M Buy
+145,690
New +$1.22M 0.06% 268

Other funds holding RGEN

Cadence Capital Management's RGEN Position: Q3 2015 in Review

Cadence Capital Management sold out of Repligen (RGEN) in Q3 2015, closing a stake of 112,670 shares — an estimated $4.65M sold.

Cadence Capital Management first reported a position in RGEN in Q2 2013 and held it in 7 quarters. The position peaked at $5.54M in Q1 2014. 184 funds tracked by Wall St. Rank hold RGEN as of Q3 2015.

  • Cadence Capital Management reported no remaining Repligen position as of Q3 2015 after selling out during the quarter.
  • Cadence Capital Management sold 112,670 Repligen shares in Q3 2015, an estimated $4.65M.
  • Cadence Capital Management first reported a position in Repligen in Q2 2013 and held it in 7 quarters.
  • Cadence Capital Management's Repligen position peaked at $5.54M in Q1 2014.
  • 184 funds tracked by Wall St. Rank held Repligen as of Q3 2015.

Based on Cadence Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.